检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:崔雪莲[1] 吴昕[1] 黎明强[1] 李艳萍[2] 马波 袁琳
机构地区:[1]柳州市疾病预防控制中心,广西柳州545007 [2]广西壮族自治区疾病预防控制中心,广西南宁530028 [3]玉溪沃森生物技术有限公司,云南玉溪653100
出 处:《现代预防医学》2015年第1期143-146,共4页Modern Preventive Medicine
基 金:广西壮族自治区卫生厅计划课题(Z2013636)
摘 要:目的了解冻干A+C群脑膜炎球菌多糖结合疫苗(MCV—A/C)在大规模人群中使用的安全性。方法对入选的9111名3~71月龄的婴幼儿接种MCV—MC,3~5月龄儿童免疫3针,每针间隔1个月;6~23月龄儿童免疫2针,每针间隔1个月;24—71月龄儿童免疫1针。对他们进行全身及局部不良反应观察和记录。结果总的局部不良反应率为1.63%,各种局部不良症状发生率分别为发红0.86%、肿胀0.54%、硬结0.48%、疼痛0.33%、瘙痒0.54%,均低于1%;总的全身不良反应率为14.98%,除发热发生率为12.75%外,其余全身不良症状发生率分别为皮疹0.78%、乏力0.42%、烦躁1.79%、呕吐0.92%、腹泻1.69%,都低于2%,全身和局部不良反应以轻度为主,且多在反应发生后3d内恢复,无疫苗引起的严重不良事件,无致残及死亡事件发生。结论冻干A+C群脑膜炎球菌多糖结合疫苗在3~71月龄的婴幼儿中大规模接种是安全的。Objective To learn the safety of freeze-dried group A/C meningococcal polysaccharide conjugate vaccine (MCV-A/C) in Chinese healthy infant and children in Liuzhou City, Guangxi Province. Methods 9111 children 3 - 71 months old were divided into 3 groups according to the age (3 - 5, 6 - 23 and 24 - 71 months). Children 3-5 months old were injected with 3 doses every month, while those at ages of 6-23 months were injected with 2 doses every month, and those 24-71 months old were injected with 1 dose. Then we observed and recorded the systemic and local adverse reactions after each dose. MCV-A/C was manufactured by Walvax Biotechnology Co., LTD. Safety was evaluated descriptively. Results The local adverse reactions rate was 1.63%, and the incidence of local adverse symptoms were less than 1%. In addition to 12.75% fever rate, the systemic adverse reaction rate was 14.98%, and the incidences for other systemic adverse symptoms were lower than 2%. Generally, the systemic and local adverse reactions were mild, and the reaction occurred within 3 days after recovery. No serious adverse event or disability or death caused by the vaccine. Conclusion MCV-A/C in the children 3 - 71 months old shows good safety, and mass immunization is safe.
关 键 词:冻干A+C群脑膜炎球菌多糖结合疫苗 安全性 大规模接种
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.171